Resident Forum
Nicotinamide: New Indications in Dermatology
FR - Nuevas indicaciones de nicotinamida en dermatología
Leído
9398
Vecesse ha leído el artículo
2506
Total PDF
6892
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 57 | 4 | 61 |
| 2025 5 | 379 | 31 | 410 |
| 2025 4 | 381 | 28 | 409 |
| 2025 3 | 267 | 26 | 293 |
| 2025 2 | 243 | 30 | 273 |
| 2025 1 | 188 | 25 | 213 |
| 2024 12 | 134 | 34 | 168 |
| 2024 11 | 155 | 59 | 214 |
| 2024 10 | 118 | 54 | 172 |
| 2024 9 | 148 | 38 | 186 |
| 2024 8 | 146 | 47 | 193 |
| 2024 7 | 116 | 32 | 148 |
| 2024 6 | 129 | 28 | 157 |
| 2024 5 | 127 | 37 | 164 |
| 2024 4 | 106 | 22 | 128 |
| 2024 3 | 92 | 34 | 126 |
| 2024 2 | 109 | 47 | 156 |
| 2024 1 | 88 | 30 | 118 |
| 2023 12 | 87 | 26 | 113 |
| 2023 11 | 94 | 26 | 120 |
| 2023 10 | 102 | 28 | 130 |
| 2023 9 | 81 | 25 | 106 |
| 2023 8 | 69 | 16 | 85 |
| 2023 7 | 106 | 24 | 130 |
| 2023 6 | 112 | 23 | 135 |
| 2023 5 | 120 | 23 | 143 |
| 2023 4 | 89 | 26 | 115 |
| 2023 3 | 104 | 23 | 127 |
| 2023 2 | 81 | 22 | 103 |
| 2022 1 | 74 | 27 | 101 |
| 2022 12 | 73 | 54 | 127 |
| 2022 11 | 29 | 23 | 52 |
| 2022 10 | 47 | 17 | 64 |
| 2022 9 | 34 | 32 | 66 |
| 2022 8 | 30 | 35 | 65 |
| 2022 7 | 31 | 30 | 61 |
| 2022 6 | 27 | 22 | 49 |
| 2022 5 | 67 | 34 | 101 |
| 2022 4 | 58 | 28 | 86 |
| 2022 3 | 78 | 56 | 134 |
| 2022 2 | 87 | 30 | 117 |
| 2021 1 | 119 | 39 | 158 |
| 2021 12 | 58 | 48 | 106 |
| 2021 11 | 78 | 55 | 133 |
| 2021 10 | 86 | 68 | 154 |
| 2021 9 | 100 | 78 | 178 |
| 2021 8 | 89 | 36 | 125 |
| 2021 7 | 92 | 38 | 130 |
| 2021 6 | 61 | 44 | 105 |
| 2021 5 | 60 | 47 | 107 |
| 2021 4 | 129 | 66 | 195 |
| 2021 3 | 87 | 31 | 118 |
| 2021 2 | 66 | 38 | 104 |
| 2020 1 | 45 | 19 | 64 |
| 2020 12 | 85 | 30 | 115 |
| 2020 11 | 51 | 20 | 71 |
| 2020 10 | 44 | 24 | 68 |
| 2020 9 | 38 | 19 | 57 |
| 2020 8 | 44 | 14 | 58 |
| 2020 7 | 51 | 30 | 81 |
| 2020 6 | 35 | 42 | 77 |
| 2020 5 | 27 | 22 | 49 |
| 2020 4 | 68 | 36 | 104 |
| 2020 3 | 29 | 27 | 56 |
| 2020 2 | 4 | 1 | 5 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 4 | 0 | 4 |
| 2019 11 | 4 | 0 | 4 |
| 2019 8 | 5 | 0 | 5 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 7 | 0 | 7 |
| 2019 5 | 4 | 0 | 4 |
| 2019 4 | 2 | 6 | 8 |
| 2019 3 | 4 | 0 | 4 |
| 2019 2 | 1 | 0 | 1 |
| 2019 1 | 3 | 0 | 3 |
| 2018 11 | 2 | 0 | 2 |
| 2018 10 | 8 | 2 | 10 |
| 2018 9 | 3 | 0 | 3 |
| 2018 2 | 30 | 9 | 39 |
| 2018 1 | 45 | 18 | 63 |
| 2017 12 | 70 | 12 | 82 |
| 2017 11 | 51 | 19 | 70 |
| 2017 10 | 57 | 15 | 72 |
| 2017 9 | 33 | 20 | 53 |
| 2017 8 | 27 | 9 | 36 |
| 2017 7 | 43 | 10 | 53 |
| 2017 6 | 33 | 19 | 52 |
| 2017 5 | 27 | 27 | 54 |
| 2017 4 | 34 | 13 | 47 |
| 2017 3 | 25 | 28 | 53 |
| 2017 2 | 29 | 24 | 53 |
| 2016 1 | 24 | 13 | 37 |
| 2016 12 | 31 | 33 | 64 |
| 2016 11 | 64 | 79 | 143 |
| 2016 10 | 5 | 21 | 26 |
| 2016 9 | 0 | 1 | 1 |
Mostrar todo
